Clinical Characteristics and Survival of Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease: A French Claims Database Analysis - Amsterdam 2025

Pulmonary hypertension associated with interstitial lung disease: screening, clinical features treatment approach and prognosis

Chair(s): Sergio Alfonso Harari, Cheng-Yu Wu

Session type: Poster session

Clinical Characteristics and Survival of Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease: A French Claims Database Analysis

Vincent Cottin

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Deep learning algorithms using non-invasive data detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis

John Wort

Poster

Abstract

Relationship between pulmonary arterial wedge pressure and survival in pulmonary hypertension associated with interstitial lung disease

Kazuya Yoshikawa

Poster

Abstract

Assessment of non-invasive parameters prior to pulmonary hypertension in fibrotic interstitial lung disease (ILD-PH)

Sophie Herbert

Poster

Abstract

High-resolution computed tomography findings of patients with pulmonary hypertension associated with interstitial lung disease: interim analysis of the PHINDER study

David Kiely

Poster

Abstract

Interim results from PHINDER: pulmonary hypertension screening in patients with interstitial lung disease for earlier detection

Sandeep Sahay

Poster

Abstract

Pulmonary vascular phenotypes in interstitial lung disease (ILD) patients: a wide scenario from a multicentric study

Giordano Fiorentu'

Poster

Abstract

Inhaled Treprostinil treatment in pulmonary hypertension associated with interstitial lung disease in an outermost region of Europe.

Carlos Ojeda Suárez

Poster

Abstract

Pulmonary Hypertension associated with Interstitial Lung Disease in the PVRI GoDeep Meta-Registry

Athiththan Yogeswaran

Poster

Abstract

PHocus: a global Phase 2 study of inhaled mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD)

H. Ardeschir Ghofrani

Poster

Abstract

Prognostic and risk stratification value of DLCO in Group 3 pulmonary hypertension

Alexandra Nagy

Poster

Abstract

Predictive factors of pulmonary hypertension in fibrosing interstitial lung diseases

David Rodríguez Plaza

Poster

Abstract

Non-invasive Screening Tools for early detection of Pulmonary Hypertension in Interstitial Lung Diseases

Giuseppe Paciocco

Poster

Abstract

Real-life use of inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease

Segolene Turquier

Poster

Abstract

Pulmonary hypertension (PH) in interstitial lung disease (ILD) patients -is it just Group 3 PH?

Pilar Rivera Ortega

Poster

Abstract

Relationship between the functional capacity and gas exchange in patiens with ILD and pulmonary hypertension: comparison between the 6-minute walk test and the 1-minute sit-to-stand test.

Ana Paola Hernández Cristancho

Poster

Abstract

Assessing cardiac MRI in the diagnosis of pulmonary hypertension in ILD patients

Vaida Averjanovaite

Poster

Abstract

Resource use and economic burden of patients with ILD-PH in France, SNDS study

Diego Funes

Poster

Abstract

Clinical Characteristics and Survival of Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease: A French Claims Database Analysis

Vincent Cottin

Poster

Abstract

Epidemiology of ILD-PH in France: Insights from the French National Health Data System

Olivier Sitbon

Poster

Abstract

Evaluation of the Utility of DLCO as a Predictive Factor for Pulmonary Hypertension Associated with Interstitial Lung Disease

Masashi Sakayori

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}